SCHEMBL1733828

SCHEMBL1733828

CCCC(CC)OC(=O)c1ccccc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.55
TSHR P16473 2/20 0.50
PRKCA P17252 2/20 0.49
PRKCD Q05655 2/20 0.49
TDP1 Q9NUW8 2/20 0.47
HPGD P15428 4/20 0.44
HSD17B10 Q99714 3/20 0.44
ALOX15 P16050 1/20 0.44
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 4/20 0.43
GAA P10253 1/20 0.43
CA2 P00918 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTT P42858 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9450061 0.90 LMNA (0.56) LMNATSHRTDP1HPGDHSD17B10
SCHEMBL234033 0.90 PRKCA (0.54) LMNATSHRPRKCAPRKCDTDP1
SCHEMBL28030230 0.90 LMNA (0.58) LMNATSHRPRKCAPRKCDTDP1
SCHEMBL63237 0.90 LMNA (0.58) LMNATSHRPRKCAPRKCDTDP1
SCHEMBL28405133 0.88 LMNA (0.56) LMNATSHRPRKCAPRKCDTDP1
SCHEMBL22684926 0.88 LMNA (0.56) LMNATSHRPRKCAPRKCDTDP1
SCHEMBL28196759 0.88 LMNA (0.56) LMNATSHRPRKCAPRKCDTDP1
SCHEMBL17907462 0.88 LMNA (0.56) LMNATSHRPRKCAPRKCDTDP1
Methane SCHEMBL28272572 0.88 LMNA (0.56) LMNATSHRPRKCAPRKCDTDP1
SCHEMBL2147881 0.88 LMNA (0.59) LMNATSHRPRKCAPRKCDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118119589-A Phenol aromatic compound precursor 奇华顿股份有限公司 2024-05-31 CN disclosed
EP-3689849-A1 PERFUME PRECURSOR Takasago International Corporation (JP) 2020-08-05 EP disclosed
US-8507564-B2 Method for selecting perfume ingredient, method for formulating fragrance, and preference-enhancing agent SHISEIDO CO., LTD. (JP) 2013-08-13 US disclosed
EP-2143782-B1 Use of Allyl Caproate SHISEIDO CO LTD (JP) 2011-11-23 EP disclosed
US-20100168253-A1 Method For Selecting Perfume Ingredient, Method For Formulating Fragrance, And Preference-Enhancing Agent SHISEIDO CO., LTD. (JP) 2010-07-01 US disclosed
EP-2143782-A1 Use of Allyl Caproate Shiseido Co., Ltd. (JP) 2010-01-13 EP disclosed
EP-1921130-A1 METHOD OF SELECTING PERFUME INGREDIENT, METHOD OF PERFUME FORMULATION, AND TASTINESS IMPROVER Shiseido Company, Limited (JP) 2008-05-14 EP disclosed
CN-1240128-A Controllable releasing method for perfume extract and compositions thereof INT FLAVORS & FRAGRANCES INC (US) 2000-01-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168253-A1 Method For Selecting Perfume Ingredient, Method For Formulating Fragrance, And Preference-Enhancing Agent HTR6, FUT6, TRPM6 LMNA 1152/4885TSHR 2115/4885PRKCA 4508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.